NCT00226525

Brief Summary

This trial is intended to find wether there is a connection between allergy to metals and reooclusion of stents in the coronary arteries

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2005

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2005

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2005

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 27, 2005

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2006

Completed
Last Updated

November 7, 2006

Status Verified

September 1, 2006

First QC Date

July 10, 2005

Last Update Submit

November 6, 2006

Conditions

Coronary Stent Restenosis

Keywords

Restenosis, skin metal allergy

Outcome Measures

Primary Outcomes (1)

  • The rate of skin delayed type hypersensitivity to metals among patients with restenosis and without restenosis

Interventions

skin sensitivity testPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with 2 cardiac catheterization in one years time and in the first one stent implantation

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Center

Jerusalem, Israel

Location

Study Officials

  • Ronen Durst, MD

    Cardiology Department Hadassah Medical Center Jerusalem Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 10, 2005

First Posted

September 27, 2005

Study Start

February 1, 2005

Study Completion

August 1, 2006

Last Updated

November 7, 2006

Record last verified: 2006-09

Locations

IL(1)